| Disease | IN THIS STUDY,52 PATIENTS WITH CANCER UNDERGOING CHEMOTHERAPY WERE GIVEN NABILONE TO TREAT CHEMOTHERAY RELATED VOMITING. THERE WERE 5 PATIENTS (9.6%) WITH AN EXCELLENT RESPONSE (MINIMAL NAUSEA,BUT NO VOMITING).
THERE WERE 28 PATIENTS (539%) WITH A GOOD RESPONSE (NAUSEA AND 50% LESS VOMITING,OR LESS THAN WITH A PREVIOUS EMETIC) AND 13 PATIENTS (25%) WITH A FAIR RESPONSE (NO DIFFERENCE WHEN COMPARED WITH PREVIOUS ANTIEMETICS).
SIX PATIENTS (11.5%) HAD A POOR RESPONSE,(LESS EFFECTIVE THAN PREVIOUS EMETICS). TOXIC EFFECTS ASSSOCIATED WITH NABILONE ARE SOMNOLENCE OR LETHARGY,DYSPHORIA,DIZZINESS,DRY MOUTH,WEAKNESS,CONFUSION,MOODINESS,VOMITING,CONSTIPATION,AND ABDOMINAL CRAMPS. |